Mercer E et al. – Hydroxychloroquine (HCQ) use for 6 weeks in non diabetic obese subjects was associated with a significant increase in Insulin Sensitivity Index (ISI) and trends toward reduced insulin resistance and insulin secretion. These data suggest that HCQ, a common medication used to treat rheumatoid arthritis (RA), possesses beneficial effects upon insulin sensitization. Further study of the insulin sensitizing effects of HCQ in patients with RA is warranted. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close